Journal Article

Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide

Paul A. Felts, Anne-Marie Woolston, Himali B. Fernando, Stephen Asquith, Norman A. Gregson, Oliver J. Mizzi and Kenneth J. Smith

in Brain

Published on behalf of The Guarantors of Brain

Volume 128, issue 7, pages 1649-1666
Published in print July 2005 | ISSN: 0006-8950
Published online May 2005 | e-ISSN: 1460-2156 | DOI: http://dx.doi.org/10.1093/brain/awh516
Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide

Show Summary Details

Preview

Inflammation is a prominent feature of several disorders characterized by primary demyelination, but it is not clear whether a relationship exists between inflammation and myelin damage. We have found that substantial demyelination results from the focal inflammatory lesion caused by the injection of lipopolysaccharide (LPS; 200 ng) directly into the rat dorsal funiculus. Within 24 h, such injections caused a focal inflammatory response consisting of a substantial number of polymorphonuclear cells and ED1-positive and inducible nitric oxide synthase (iNOS)-positive macrophages/microglia. The number of inflammatory cells was substantially reduced by day 7. OX-52-positive T-cells were less frequently observed but were present in the meninges at 8 h, reached a maximum in the dorsal funiculus at 7 days, and were rare at 14 days. The inflammation was followed by the appearance of a large lesion of primary demyelination that encompassed up to ∼75% of the cross-sectional area of the dorsal funiculus. Treatment with dexamethasone significantly reduced the number of cells expressing iNOS, but did not prevent the demyelination. By 28 days the lesions were largely remyelinated, usually by Schwann cells. These changes were not observed in control, saline-injected animals. We conclude that the intraspinal injection of LPS results in inflammation and subsequently in prominent demyelination. The mechanisms underlying the demyelination are not clear, but it is notable that it typically begins with disruption of the adaxonal myelin. Indeed, there is an early loss of myelin-associated glycoprotein within the lesion, despite the persistence of proteolipid protein. This combination is a feature of the pattern III lesion recently described in multiple sclerosis (Lucchinetti et al., 2000), and we therefore suggest that LPS-induced demyelination may serve as the first experimental model available for the study of this type of multiple sclerosis lesion.

Keywords: multiple sclerosis; models; microglia; inflammation; demyelination; AdPC = adenomatous polyposis coli; GFAP = glial fibrillary acidic protein; ICAM-1 = intercellular adhesion molecule-1; iNOS = inducible form of nitric oxide synthase; LPS = lipopolysaccharide; MAG = myelin-associated glycoprotein; PBS = phosphate-buffered saline; PLP = proteolipid protein; PMN = polymorphonuclear cell

Journal Article.  10859 words.  Illustrated.

Subjects: Neurology ; Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.